These are the stocks posting the largest moves before the bell.Market Insiderread more
The Fed is expected to cut rates Wednesday, but it is unlikely to tell markets what they want to hear on future rate cuts.Market Insiderread more
The trade war between the United States and China has lasted for more than one year — and a resolution is nowhere in sight.World Economyread more
Mortgage applications to purchase a home increased 6% for the week and were a strong 15% higher annually.Real Estateread more
The House subcommittee that oversees consumer product investigations launched its a probe of Juul in June, holding two days of hearings in July. In a letter to Juul sent...Health and Scienceread more
Pelosi said Trump should not have tried to address China's trade practices in a way that opened Americans up to financial pain.Politicsread more
Corporate buyback trades are ripe for being picked off by high speed firms, effectively siphoning millions of dollars from the companies.Marketsread more
Here's CNBC review of the Apple Watch Series 5, which makes a step forward with an always-on display and a useful compass that can help you find your way on Apple Maps.Technologyread more
On Sept. 18, Capital One and Walmart announced the launch of the Capital One Walmart Rewards Credit Card Program, which offers two new cobranded credit cards. Here's a break...Moneyread more
FedEx is gearing up to report earnings after the bell Tuesday. Here's what to expect.Trading Nationread more
DoubleLine CEO Jeffrey Gundlach believes the bottom for interest rates is in for 2019.Marketsread more
Kentucky has sued Walgreens for its role in the state's opioid epidemic.
Attorney General Andy Beshear filed the suit against Walgreens for its dual role as a distributor and a pharmacy, saying it allegedly failed to monitor its own operations and shipped and dispensed large amounts of opioids.
Beshear said Walgreens flooded Kentucky with opioid prescriptions at its more than 70 locations across the state, "directly contributing to the state's drug epidemic." The lawsuit alleges "unfair, misleading and deceptive business practices by Walgreens for excessively distributing and dispensing opioids in Kentucky and for failing to legally report to state and federal authorities the suspiciously large orders it received for prescription opioids."
A spokesman for Walgreens Boots Alliance declined to comment on pending litigation.
This is the sixth opioid-related suit Beshear has filed. He's sued three drug distributors, AmerisourceBergen, which Walgreens Boots Alliance owns a roughly 26 percent stake in, McKesson and Cardinal Health. He's also sued pharmaceutical manufacturers, including Johnson & Johnson.
Cities, counties and states around the country are suing companies across the drug supply chain for their alleged roles in the opioid epidemic. They've accused manufacturers of downplaying painkillers' risk of addiction, distributors of allegedly flooding communities with pills and pharmacies for allegedly failing to flag suspicious prescriptions.
Kentucky has been one of the states hit hardest by the opioid epidemic that has ravaged communities across the country. The state's opioid-related overdose death rate was nearly double the national rate in 2016, according to the National Institute on Drug Abuse.